Altimmune, Inc. - COM NEW (ALT)

Historical Portfolio Holders from Q3 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
39.5M
Holdings value Q3 2024
$243M
Value change Q3 2024
-$19.8M
Grand Portfolio weight change Q3 2024
0%
Number of holders
166
Number of buys Q3 2024
78
Number of sells Q3 2024
-71
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 39.5M $243M -$19.8M $6.14 167
2024 Q2 42.4M $282M -$21.5M $6.65 175
2024 Q1 44.3M $451M +$109M $10.18 166
2023 Q4 33.5M $377M +$87.7M $11.25 143
2023 Q3 30.1M $78.3M -$14.3M $2.60 111
2023 Q2 35.3M $125M -$31M $3.53 118
2023 Q1 40.1M $169M -$115M $4.22 133
2022 Q4 46.8M $770M +$29.5M $16.45 126
2022 Q3 46M $588M +$80.6M $12.77 120
2022 Q2 39.9M $467M +$78.8M $11.70 105
2022 Q1 33.7M $207M +$5.87M $6.09 97
2021 Q4 32.5M $296M -$27.2M $9.16 99
2021 Q3 32.1M $363M +$59.1M $11.31 115
2021 Q2 27.2M $268M +$16.7M $9.85 105
2021 Q1 23.8M $337M +$49.6M $14.13 93
2020 Q4 20.5M $231M -$28.7M $11.28 83
2020 Q3 21.9M $289M +$116M $13.20 70
2020 Q2 13.3M $143M +$125M $10.71 57
2020 Q1 1.58M $5.08M +$1.21M $3.21 22
2019 Q4 1.28M $2.42M +$315K $1.89 21
2019 Q3 1.11M $2.17M +$160K $1.95 22
2019 Q2 1.03M $2.46M -$456K $2.37 15
2019 Q1 1.11M $3.23M +$1.23M $2.90 13
2018 Q4 807K $1.66M +$929K $2.06 18
2018 Q3 194K $853K +$853K $4.40 7